Clinical Trial Results - Progress in Cancer Care
These summaries highlight recently released results from cancer clinical trials. The findings are significant enough that they are likely to influence your medical care.
The summaries are listed in reverse chronological order. You may also use the navigation tools on the left to search the summaries by keyword or type of cancer.
(Posted: 08/12/2010) - Patients newly diagnosed with metastatic non-small cell lung cancer (NSCLC) who received gefitinib (Iressa) had significantly higher response rates and longer progression-free survival compared with patients who received carboplatin plus paclitaxel, according to results of a phase III trial conducted in Japan.
HPV Status Can Predict Outcome in Oropharyngeal Cancer
(Posted: 06/19/2009, Updated: 08/09/2010) - Patients with advanced oropharyngeal cancer are more likely to survive if their tumors are HPV positive than if they are HPV negative, according to findings presented at the 2009 ASCO meeting in Orlando.
Single-Dose Partial Breast Irradiation Safe for Some Women with Invasive Breast Cancer
(Posted: 07/08/2010, Updated: 08/04/2010) - A study published online June 5, 2010, in The Lancet shows that for some women with invasive breast cancer a single dose of radiotherapy delivered at the time of surgery may be an alternative to a standard course of external beam radiotherapy.
Adding Radiation to Hormone Therapy Improves Survival in Locally Advanced Prostate Cancer
(Posted: 07/08/2010) - Adding radiotherapy to androgen deprivation therapy (ADT) improves survival in men with locally advanced prostate cancer, according to findings presented at the 2010 ASCO meeting in Chicago.
Trials Point to More Treatment Options for Chronic Myeloid Leukemia
(Posted: 07/08/2010) - Two studies published online June 5, 2010, in the New England Journal of Medicine found that two second-generation kinase inhibitors outperform imatinib, at least over the short term, in patients with chronic myelogenous leukemia.